Developer docs
API playgroundTry for free, no card

Search company profiles

Augmedics

Full company profile

uuid0000gc6

Namestring
Augmedics
Legal namestring
Augmedics Inc.
Websiteurl
augmedics.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Augmedics is a privately held medical device company founded in 2014 and headquartered in Arlington Heights, Illinois, that develops augmented reality (AR) surgical navigation systems for spine surgery. Its flagship product, the xvision Spine System, is the first FDA-cleared (December 2019) AR guidance platform for surgery, consisting of proprietary headset hardware (including the next-generation X2 headset FDA-cleared in November 2025) and software that superimposes 3D anatomical data onto the surgeon's view of the operative field, eliminating the need to look away at distant screens. The system supports open, minimally invasive (MIS), and percutaneous spine procedures from C3 to the pelvis, and incorporates an AI-powered CT-Fluoro registration method (FDA-cleared November 2024) that allows navigation using preoperative CT scans paired with standard 2D C-arm fluoroscopy, bypassing the need for expensive 3D intraoperative imaging. Reported clinical outcomes include 11,746+ patients treated and 64,672+ screws navigated, with peer-reviewed pedicle screw placement accuracy of 89.5-100%.

The company operates a direct enterprise field sales model targeting hospitals and academic medical centers, including named adopters such as Johns Hopkins, Rush University Medical Center, UConn Health, Hospital for Special Surgery, Penn Medicine, and UC Davis Health. Revenue is generated primarily through capital equipment sales of the xvision hardware platform with multi-year service and support contracts, complemented by a Federal Supply Schedule contract with the Veterans Health Administration. Augmedics has raised approximately $141.8 million across four disclosed funding rounds (Series A $8.3M in 2017, Series B $15M in 2020, Series C $36M in 2021, Series D $82.5M in 2023) from investors including H.I.G. Capital, Revival Healthcare Capital, Evidity Health Capital, CPMG, Almeda Ventures, and HCA Healthcare. In a material strategic shift, CEO Paul Ziegler announced the company's exit from the spine market in January 2026, and VB Spine subsequently acquired exclusive rights to the xvision Spine System in April 2026, though Augmedics Inc. continues to operate as a corporate entity.

Short descriptiontext

Augmedics is a medical device company that develops the FDA-cleared xvision Spine System, an augmented reality surgical navigation platform enabling spine surgeons to visualize 3D anatomy through an AR headset while operating, sold to hospitals and academic medical centers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersArlington Heights, United States
HQ citystring
Arlington Heights
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
augmented reality navigation, surgical navigation systems, spine surgery technology, medical imaging devices, computer-assisted surgery
Industry4 codes
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Surgical Navigation and Imaging Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1AR Surgical Navigation Hardware Systems
TypeHardware Sales
Description

Sale of proprietary X2 headset and xvision Spine System hardware to hospitals and surgical centers. Capital equipment model with one-time hardware sales.

augmedics.com
2Navigation Services and Support
TypeSubscription Recurring
Description

Ongoing support, maintenance, and potentially software subscription services for the navigation platform.

augmedics.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others
Pricing details1 tier
1Enterprise hospital systems - custom pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing available. Capital equipment typically sold through direct sales with custom quotes based on facility requirements.

augmedics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1xvision Spine System
Description

FDA-cleared augmented reality surgical navigation system for spine surgery, allowing surgeons to visualize patient anatomy in 3D while looking directly at the patient.

augmedics.com
+1 more record
Core offering1 text field

Augmedics develops and sells the xvision Spine System, an FDA-cleared augmented reality surgical navigation platform consisting of a proprietary AR headset (X2) and AI-enabled registration software. The system allows surgeons to visualize 3D patient anatomy directly in their line of sight during spine procedures, enabling image-guided pedicle screw placement for open, minimally invasive, and percutaneous cases from C3 to the pelvis. Revenue is generated through capital hardware sales plus recurring service and support to hospitals and surgical centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 97-100% pedicle screw placement accuracy across multiple patient studies
+4 more records
Product overview1 text field

Augmedics offers a unified augmented reality surgical navigation platform centered on the xvision Spine System. The core system comprises the FDA-cleared xvision software platform combined with dedicated AR headsets (first-generation and X2 next-generation). Add-on capabilities include CT-Fluoro registration enabling navigation off preoperative CT and standard 2D fluoroscopy. The platform enables surgeons to visualize patient anatomy in 3D through tissue during spine procedures, with the headset superimposing surgical data onto the operative field.

Product and service3 records
1xvision Spine System
CategoryCore product — AR surgical navigation platform
Description

FDA-cleared augmented reality surgical navigation system that allows surgeons to visualize patient anatomy in 3D while looking directly at the patient, providing x-ray vision during spine procedures. Supports navigation of instruments and implants for open, MIS, and percutaneous spine procedures from C3 to pelvis. Sold as a platform to hospitals and academic medical centers.

2X2 AR Headset
CategoryCore product — AR surgical headset hardware
Description

Next-generation AR headset purpose-built for surgery and use with the xvision Spine System. Offers an all-new form factor with detachable surgical-grade headlight, 100% increased field of view versus its predecessor, improved image resolution and brightness, and an ergonomic novel lens tilt enabling both standing and seated procedures. Sold to hospitals and surgical centers as the wearable component of the xvision platform.

3xvision AI Application
CategoryCore product — AI software feature for surgical navigation
Description

AI-enabled software capability launched as part of the xvision platform in March 2023, expanding the system's indications and automated features for AR spine surgical navigation. Sold to hospitals and surgical centers as part of the xvision platform.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-04-13
Description

VB Spine LLC completed acquisition of exclusive rights to xvision Spine System from Augmedics in April 2026. The xvision system had been used in nearly 13,000 spinal procedures and is FDA-cleared for use in the US. VB Spine plans to operationalize and commercialize the platform. This transaction represents Augmedics' exit from the spine market following CEO Paul Ziegler's January 2026 announcement.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2023-07-31
Description

Augmedics acquired digital health assets from Surgalign (including Holo Surgical) in 2023 to strengthen its AR/AI portfolio. The acquisition expanded Augmedics' intellectual property portfolio and digital health technology capabilities.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Munich-based surgical navigation and digital OR platform company offering image-guided navigation systems used in spine, neurosurgery, and orthopedics. Direct competitor to xvision in surgical navigation with established hospital installed base.

TypeDirect peer
Description

Spine-focused medical device company with the ExcelsiusGPS robotic navigation platform — directly competes with Augmedics in spine surgical navigation and offers an integrated implant + robotics portfolio.

TypeBroad incumbent
Description

Diversified medtech incumbent with the Mazor X spine robotics platform and StealthStation surgical navigation — broad incumbent competing in spine navigation/robotics with significantly larger R&D and commercial footprint.

TypeBroad incumbent
Description

Multi-specialty medtech incumbent with spine navigation (SpineMap) and surgical visualization offerings. Broad incumbent providing overlapping navigation capabilities as part of a much wider device portfolio.

TypeDirect peer
Description

Pure-play spine medical device company offering surgical solutions including navigation and Pulse platform. Direct competitor in spine surgery with overlapping customer base of hospital spine programs.

TypeBroad incumbent
Description

Diversified orthopedic medtech incumbent with the ROSA Spine robotic navigation platform. Broad incumbent overlapping in surgical navigation and robotic-assisted spine surgery.

TypeEmerging player
Description

French surgical robotics company focused on spine navigation and robotic-assisted surgery; partnered with DePuy Synthes in 2024. Emerging player with partial overlap in spine AR/navigation that intersects with Augmedics' core capability.

TypeEmerging player
Description

Seattle-based developer of an AI-enabled surgical visualization platform for spine and neurosurgery using light-field technology. Emerging player pursuing AR-style surgical guidance with a different technical approach but comparable end use case.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds7 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors14 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Augmedics

Surgical Navigation and Imaging Equipmentaugmedics.com

Augmedics is a medical device company that develops the FDA-cleared xvision Spine System, an augmented reality surgical navigation platform enabling spine surgeons to visualize 3D anatomy through an AR headset while operating, sold to hospitals and academic medical centers.

What Augmedics does

Augmedics is a privately held medical device company founded in 2014 and headquartered in Arlington Heights, Illinois, that develops augmented reality (AR) surgical navigation systems for spine surgery. Its flagship product, the xvision Spine System, is the first FDA-cleared (December 2019) AR guidance platform for surgery, consisting of proprietary headset hardware (including the next-generation X2 headset FDA-cleared in November 2025) and software that superimposes 3D anatomical data onto the surgeon's view of the operative field, eliminating the need to look away at distant screens. The system supports open, minimally invasive (MIS), and percutaneous spine procedures from C3 to the pelvis, and incorporates an AI-powered CT-Fluoro registration method (FDA-cleared November 2024) that allows navigation using preoperative CT scans paired with standard 2D C-arm fluoroscopy, bypassing the need for expensive 3D intraoperative imaging. Reported clinical outcomes include 11,746+ patients treated and 64,672+ screws navigated, with peer-reviewed pedicle screw placement accuracy of 89.5-100%.

The company operates a direct enterprise field sales model targeting hospitals and academic medical centers, including named adopters such as Johns Hopkins, Rush University Medical Center, UConn Health, Hospital for Special Surgery, Penn Medicine, and UC Davis Health. Revenue is generated primarily through capital equipment sales of the xvision hardware platform with multi-year service and support contracts, complemented by a Federal Supply Schedule contract with the Veterans Health Administration. Augmedics has raised approximately $141.8 million across four disclosed funding rounds (Series A $8.3M in 2017, Series B $15M in 2020, Series C $36M in 2021, Series D $82.5M in 2023) from investors including H.I.G. Capital, Revival Healthcare Capital, Evidity Health Capital, CPMG, Almeda Ventures, and HCA Healthcare. In a material strategic shift, CEO Paul Ziegler announced the company's exit from the spine market in January 2026, and VB Spine subsequently acquired exclusive rights to the xvision Spine System in April 2026, though Augmedics Inc. continues to operate as a corporate entity.

Augmedics firmographics

Firmographics
Name
Augmedics
Legal name
Augmedics Inc.
Website
https://augmedics.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
Augmedics is a medical device company that develops the FDA-cleared xvision Spine System, an augmented reality surgical navigation platform enabling spine surgeons to visualize 3D anatomy through an AR headset while operating, sold to hospitals and academic medical centers.
Ownership category
akta.pro rank

Augmedics industry classification

Industry
Product category
Surgical Navigation and Imaging Equipment
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAH
Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Augmented reality navigation
  • Surgical navigation systems
  • Spine surgery technology
  • Medical imaging devices
  • Computer-assisted surgery

Where Augmedics is headquartered

Location

Headquarters

HQ city
Arlington Heights
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Augmedics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

  1. AR Surgical Navigation Hardware Systems: Sale of proprietary X2 headset and xvision Spine System hardware to hospitals and surgical centers. Capital equipment model with one-time hardware sales.
  2. Navigation Services and Support: Ongoing support, maintenance, and potentially software subscription services for the navigation platform.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise hospital systems - custom pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Augmedics product offering

Product offering

Core offering

Augmedics develops and sells the xvision Spine System, an FDA-cleared augmented reality surgical navigation platform consisting of a proprietary AR headset (X2) and AI-enabled registration software. The system allows surgeons to visualize 3D patient anatomy directly in their line of sight during spine procedures, enabling image-guided pedicle screw placement for open, minimally invasive, and percutaneous cases from C3 to the pelvis. Revenue is generated through capital hardware sales plus recurring service and support to hospitals and surgical centers.

Product overview

Augmedics offers a unified augmented reality surgical navigation platform centered on the xvision Spine System. The core system comprises the FDA-cleared xvision software platform combined with dedicated AR headsets (first-generation and X2 next-generation). Add-on capabilities include CT-Fluoro registration enabling navigation off preoperative CT and standard 2D fluoroscopy. The platform enables surgeons to visualize patient anatomy in 3D through tissue during spine procedures, with the headset superimposing surgical data onto the operative field.

Differentiator

Problem solved

Functional benefit

Brands

  • xvision Spine System: FDA-cleared augmented reality surgical navigation system for spine surgery, allowing surgeons to visualize patient anatomy in 3D while looking directly at the patient.
  • X2

Products and services

  • xvision Spine System FDA-cleared augmented reality surgical navigation system that allows surgeons to visualize patient anatomy in 3D while looking directly at the patient, providing x-ray vision during spine procedures. Supports navigation of instruments and implants for open, MIS, and percutaneous spine procedures from C3 to pelvis. Sold as a platform to hospitals and academic medical centers.
  • X2 AR Headset Next-generation AR headset purpose-built for surgery and use with the xvision Spine System. Offers an all-new form factor with detachable surgical-grade headlight, 100% increased field of view versus its predecessor, improved image resolution and brightness, and an ergonomic novel lens tilt enabling both standing and seated procedures. Sold to hospitals and surgical centers as the wearable component of the xvision platform.
  • xvision AI Application AI-enabled software capability launched as part of the xvision platform in March 2023, expanding the system's indications and automated features for AR spine surgical navigation. Sold to hospitals and surgical centers as part of the xvision platform.

Quantifiable outcome

  • 97-100% pedicle screw placement accuracy across multiple patient studies
  • +4 more outcomes

Companies that use Augmedics

Customer profile

Named customers7 records

Segments1 record

Ideal customer profiles1 record

Augmedics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Augmedics partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major and core.

  • VB SpinemajorOEM/ Whitelabel/ Licensing Partner · 13 April 2026VB Spine LLC completed acquisition of exclusive rights to xvision Spine System from Augmedics in April 2026. The xvision system had been used in nearly 13,000 spinal procedures and is FDA-cleared for use in the US. VB Spine plans to operationalize and commercialize the platform. This transaction represents Augmedics' exit from the spine market following CEO Paul Ziegler's January 2026 announcement.
  • SurgaligncoreTechnology or Integration · 31 July 2023Augmedics acquired digital health assets from Surgalign (including Holo Surgical) in 2023 to strengthen its AR/AI portfolio. The acquisition expanded Augmedics' intellectual property portfolio and digital health technology capabilities.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Augmedics competitors and assessment

Company assessment

Direct peers

  • Brainlab: Munich-based surgical navigation and digital OR platform company offering image-guided navigation systems used in spine, neurosurgery, and orthopedics. Direct competitor to xvision in surgical navigation with established hospital installed base.
  • Globus Medical: Spine-focused medical device company with the ExcelsiusGPS robotic navigation platform — directly competes with Augmedics in spine surgical navigation and offers an integrated implant + robotics portfolio.
  • NuVasive: Pure-play spine medical device company offering surgical solutions including navigation and Pulse platform. Direct competitor in spine surgery with overlapping customer base of hospital spine programs.

Broad incumbents

  • Medtronic: Diversified medtech incumbent with the Mazor X spine robotics platform and StealthStation surgical navigation — broad incumbent competing in spine navigation/robotics with significantly larger R&D and commercial footprint.
  • Stryker: Multi-specialty medtech incumbent with spine navigation (SpineMap) and surgical visualization offerings. Broad incumbent providing overlapping navigation capabilities as part of a much wider device portfolio.
  • Zimmer Biomet: Diversified orthopedic medtech incumbent with the ROSA Spine robotic navigation platform. Broad incumbent overlapping in surgical navigation and robotic-assisted spine surgery.

Emerging players

  • eCential Robotics: French surgical robotics company focused on spine navigation and robotic-assisted surgery; partnered with DePuy Synthes in 2024. Emerging player with partial overlap in spine AR/navigation that intersects with Augmedics' core capability.
  • Proprio Vision: Seattle-based developer of an AI-enabled surgical visualization platform for spine and neurosurgery using light-field technology. Emerging player pursuing AR-style surgical guidance with a different technical approach but comparable end use case.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Augmedics social profiles

Digital presence

Augmedics compliance and trust

Trust signal

Compliance2 records

Augmedics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Augmedics leadership team

Management profile

Number of profiles

Profiles10 records

Augmedics funding detail

Funding detail

Funding overview

Funding rounds7 records

Investors14 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Augmedics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Augmedics

What does Augmedics do?

Augmedics develops and sells the xvision Spine System, an FDA-cleared augmented reality surgical navigation platform consisting of a proprietary AR headset (X2) and AI-enabled registration software. The system allows surgeons to visualize 3D patient anatomy directly in their line of sight during spine procedures, enabling image-guided pedicle screw placement for open, minimally invasive, and percutaneous cases from C3 to the pelvis. Revenue is generated through capital hardware sales plus recurring service and support to hospitals and surgical centers.

Is Augmedics a public or private company?

Augmedics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Augmedics founded?

Augmedics was founded in 2014. It employs 51 to 100 people.

Where is Augmedics based?

Augmedics is headquartered in Arlington Heights, United States, in the North America region.

How does Augmedics make money?

Two revenue lines are on record. AR Surgical Navigation Hardware Systems are the primary driver. The others are navigation Services and Support.

Who are Augmedics's main competitors?

Direct peers on record are Brainlab, Globus Medical and NuVasive. Broad incumbents are Medtronic, Stryker and Zimmer Biomet. Emerging players are eCential Robotics and Proprio Vision.

Does Augmedics have an API?

No public API is recorded for Augmedics.

What industry is Augmedics in?

Augmedics's product category is Surgical Navigation and Imaging Equipment. Its primary akta.pro industry code is HLAHADAG, Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT), with a secondary code of HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms. Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MedicalEconomicsVB Spine completes acquisition of Augmedics' CT-fluoroscopy technology for xvision platformVB Spine LLC has completed the acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy technology for spine applications and will integrate it into its xvision platform. This addition provides a new registration method using standard 2D C-arm fluoroscopy, aiming to lower equipment costs and expand access to augmented reality navigation in smaller hospitals and ambulatory surgery centers.Medical Device and Diagnostic industryVB Spine Acquires Augmedics CT-Fluoro Tech RightsVB Spine has entered into a definitive agreement to acquire the exclusive rights to Augmedics’ CT-to-fluoroscopy technology for spine applications. This transaction expands VB Spine's xvision platform capabilities by allowing surgeons to register preoperative CT scans using standard fluoroscopic imaging, thereby reducing the need for intraoperative 3D imaging systems. The deal follows previous acquisitions of other Augmedics platforms and technologies earlier in the year.TodaysmedicaldevelopmentsVB Spine acquires Augmedics’ CT-to-fluoroscopy technologyVB Spine LLC has completed the acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy technology for spine applications and will integrate it into its xvision Spine System platform. This strategic move aims to expand augmented reality navigation options for surgeons, particularly in cost-sensitive settings like regional hospitals and ambulatory surgery centers.BioSpaceVB Spine Completes Transaction for CT-Fluoro Technology from AugmedicsVB Spine completed its acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications and will integrate it into the xvision Spine System platform. The technology uses preoperative CT scans and fluoroscopic images to support augmented reality navigation, expanding imaging options for surgeons. VB Spine and Augmedics are working to ensure a seamless transition.Business Wire BlogVB Spine Completes Transaction for CT-Fluoro Technology from AugmedicsVB Spine has completed the acquisition of exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications. The company will immediately integrate this augmented reality navigation tool into its xvision Spine System platform to expand imaging options for surgeons. This move aims to make AR-guided spine surgery more accessible in regional hospitals and ambulatory surgery centers where traditional 3D imaging systems are cost-prohibitive.FinancialContent Business PageVB Spine Completes Transaction for CT-Fluoro Technology from AugmedicsVB Spine LLC has completed the acquisition of exclusive rights to Augmedics' CT-Fluoro technology for spine applications. The company will immediately integrate this technology into its xvision Spine System platform to enhance augmented reality navigation for surgeons. This move aims to expand access to AR-guided surgery in settings where traditional 3D imaging systems are cost-prohibitive.Built In ChicagoChicago’s Top Tech Funding Rounds Totaled $202.5M in JuneChicago tech companies raised $202.5 million in June 2023, more than double May's $100.7 million. The largest round was Augmedics' $82.5 million Series D, followed by Fly.io's $70 million. The funds will support platform development, expansion, and profitability.Built In ChicagoAugmedics Raises $36M to Give Surgeons the Power of X-Ray VisionAugmedics has closed a $36 million Series C funding round, bringing its total capital raised to $63 million. The company plans to use these funds to expand into new markets, including Europe, and to develop next-generation surgical products beyond spine surgery.Medical BuyerVB Spine to acquire CT-Fluoro tech from AugmedicsVB Spine LLC has entered into a definitive agreement to acquire exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications, building on its April acquisition of the xvision Spine System platform. The technology enables surgeons to register preoperative CT scans using standard fluoroscopic imaging, potentially eliminating the need for intraoperative CT or 3D imaging systems during spine procedures and reducing imaging requirements. The transaction, subject to customary closing conditions and regulatory requirements, will expand workflow flexibility and increase access to augmented reality navigation across more surgical facilities.YahooVB Spine to acquire rights to Augmedics’ CT-Fluoro technologyUS-based medical technology company VB Spine has signed a definitive agreement with Augmedics to acquire exclusive rights to CT-Fluoro technology for spine applications. The technology enables surgeons to register a patient's preoperative CT scan using standard fluoroscopic imaging, potentially reducing reliance on intraoperative CT or 3D imaging systems during spinal procedures. The transaction is subject to standard closing conditions and regulatory approvals, with specific financial details not disclosed.